Cafepharma Today

May 15 2025 - FDA approves Amneal's self-administered migraine treatment
FDA approves Amneal's self-administered migraine treatment
VC firm reveals plan for 30K-square-foot biotech incubator space in New Jersey
Philips taps Nvidia to build AI model for MRI
FDA delays decision on Biohaven's rare disease drug filing, plans adcomm
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Merck's Proscar Fails to Win U.S. FDA Panel's Backing for Prostate Cancer
Bloomberg
Wednesday, December 1, 2010 - 5:55pm
tags:
Merck, Proscar, FDA, prostate cancer
For GSK, It’s Last Call For a Drug Based on Resveratrol
WSJ Online
Wednesday, December 1, 2010 - 5:54pm
tags:
GSK, Resveratrol
Somaxon: A Bargain Buy Pharma
Seeking Alpha
Wednesday, December 1, 2010 - 5:42pm
tags:
Somaxon, Silenor
Splitting Up Pfizer Won’t Help The Troubled Company
Forbes
Wednesday, December 1, 2010 - 5:40pm
tags:
Pfizer
2010 Pharma job cuts cross the 50K mark
Fierce Pharma
Wednesday, December 1, 2010 - 12:27pm
tags:
layoffs
Novartis Sales Force Job Eliminations a Cause for Concern
Seeking Alpha
Wednesday, December 1, 2010 - 12:20pm
tags:
Novartis, drug reps, layoffs
The Amgen Sales Rep, The Doctor And The Dog
Pharmalot
Wednesday, December 1, 2010 - 12:10pm
tags:
Amgen, drug reps, physicians
Sanofi-Aventis Unlikely to Raise Offer for Genzyme
CNBC
Wednesday, December 1, 2010 - 12:09pm
tags:
Genzyme, M&A, Sanofi
How Cheap Is Gilead Sciences' Stock by the Numbers?
Motley Fool
Wednesday, December 1, 2010 - 12:09pm
tags:
Gilead Sciences
Docs Like Reps From Which Company The Most?
Pharmalot
Wednesday, December 1, 2010 - 11:37am
tags:
drug reps, physicians, GSK
Axcan buying Eurand for $583 million
Yahoo/AP
Wednesday, December 1, 2010 - 11:35am
tags:
Aptalis, M&A
Allergan Lap-Band Effective in Treating More Obese People, FDA Staff Says
Bloomberg
Wednesday, December 1, 2010 - 11:29am
tags:
Allergan, obesity, Lap-Band, FDA
Tylenol plant still plagued by FDA violations
CNN Money
Wednesday, December 1, 2010 - 11:25am
tags:
JNJ, recalls, FDA, Tylenol
Pharmaceutical Company Restructuring Considerations for the Future
Pharmareform
Wednesday, December 1, 2010 - 8:58am
tags:
restructuring
Wyeth Execs Can’t Hide Behind Silence on Antidepressant Data
BNET Pharma
Wednesday, December 1, 2010 - 8:20am
tags:
Wyeth, Pristiq, antidepressants
Teva Announces $1 Billion Share Repurchase Program
Yahoo
Wednesday, December 1, 2010 - 8:11am
tags:
Teva Pharmaceuticals, share repurchase
Simcere Pharmaceutical Group Shares Popped: What You Need to Know
Motley Fool
Wednesday, December 1, 2010 - 8:11am
tags:
China, Simcere
J&J Says $2.3 Billion Crucell Deal May Still Be Renegotiated
Bloomberg
Wednesday, December 1, 2010 - 8:10am
tags:
JNJ, M&A, Crucell, vaccines
Better Buy: Exact Sciences or Sequenom?
Motley Fool
Wednesday, December 1, 2010 - 8:09am
tags:
Sequenom, EXACT Sciences
Bristol-Myers, Otsuka's Schizophrenia Drug Backed for Teens by U.K. Agency
Bloomberg
Wednesday, December 1, 2010 - 8:08am
tags:
Bristol-Myers Squibb, Otsuka, schizophrenia, aripiprazole, UK, Abilify

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.